EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Proteomic screening identifies HNRNPA2B1 as an epigenetic repressor of Epstein-Barr virus reactivation

Febri Gunawan Sugiokto iD, Yuxin Liu, Renfeng Li iD

Journal of Virology · 21.07.2026 · 100 (7)

DOI: 10.1128/jvi.00613-26 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 21.07.2026. Verfasst von Febri Gunawan Sugiokto und 2 weiteren Autor:innen. Beteiligte Einrichtung: Program in Microbiology and Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Herpesvirus 4, Human, Heterogeneous-Nuclear Ribonucleoprotein Group A-B, Epigenesis, Genetic, Virus Activation. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epstein-Barr virus (EBV) establishes lifelong persistent infection in over 90% of the world’s population. The virus persists as an episome in the host cells during latency and periodically reactivates through transcriptional activation of the immediate-early (IE) genes. While epigenetic regulation is central to maintaining viral latency, the host factors that enforce repression at these promoters remain incompletely defined. Here, we employed a novel Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas9-based en gineered DNA-binding molecule-mediated ch romatin i mmuno p recipitation coupled with m ass s pectrometry (enChIP-MS) approach to identify proteins associated with the promoter of EBV IE gene ZTA . This approach revealed an enrichment of multiple heterogeneous nuclear ribonucleoproteins and identified HNRNPA2B1 as a potential regulator of EBV ZTA gene expression. Functional analyses across multiple EBV+ cancer cell models demonstrated that HNRNPA2B1 acts as a restriction factor for EBV lytic reactivation. Depletion of HNRNPA2B1 led to increased expression of IE and downstream lytic genes, enhanced RNA polymerase II recruitment to the ZTA and RTA promoters, and elevated the proportion of cells entering the lytic cycle. Conversely, enforced expression of HNRNPA2B1 suppressed EBV lytic reactivation. Mechanistically, HNRNPA2B1 enhances repressive viral chromatin states by facilitating recruitment of the histone demethylase LSD1 to EBV IE gene promoters, thereby limiting the activating histone H3 lysine 4 trimethylation. Together, these findings identify HNRNPA2B1 as a key epigenetic regulator of EBV latency and link RNA-binding proteins to epigenetic control of viral reactivation. IMPORTANCE This study identifies HNRNPA2B1 as a previously unrecognized host factor that promotes Epstein-Barr virus (EBV) latency through direct regulation of viral chromatin at immediate-early gene promoters. By integrating locus-specific chromatin proteomics with functional and mechanistic analyses, our work reveals how an RNA-binding protein HNRNPA2B1 recruits a histone-modifying enzyme to control EBV reactivation. These findings provide new insights into host-virus interactions that control EBV latency and reactivation and highlight the role of RNA-binding proteins in chromatin regulation that may be broadly relevant to other latent DNA viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 4, HumanHeterogeneous-Nuclear Ribonucleoprotein Group A-BEpigenesis, GeneticVirus ActivationEpstein-Barr Virus InfectionsHumansProteomicsHistone DemethylasesPromoter Regions, GeneticGene Expression Regulation, ViralTrans-ActivatorsVirus LatencyHistonesImmediate-Early ProteinsChromatin ImmunoprecipitationCRISPR-Cas SystemsHost-Pathogen InteractionsCell Line, Tumor

Stichwörter der Autor:innen

CRISPREpstein-Barr virusH3K4Me3HNRNPA2B1Kaposi's sarcoma-associated herpesvirusLSD1RNA-binding proteinsenChIP-MSlatencyreactivation

Substanzen

Heterogeneous-Nuclear Ribonucleoprotein Group A-BHistone DemethylasesTrans-ActivatorsKDM1A protein, humanBZLF1 protein, Herpesvirus 4, HumanHistoneshnRNP A2Immediate-Early Proteins

Autor:innen und Institutionen

  • Program in Microbiology and Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Microbiology and Molecular Genetics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Cancer Virology Program, Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Febri Gunawan Sugiokto, Renfeng Li

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Sugiokto, F. G., Liu, Y., & Li, R. (2026). Proteomic screening identifies HNRNPA2B1 as an epigenetic repressor of Epstein-Barr virus reactivation. Journal of Virology, 100(7). https://doi.org/10.1128/jvi.00613-26

Vancouver

Sugiokto FG, Liu Y, Li R. Proteomic screening identifies HNRNPA2B1 as an epigenetic repressor of Epstein-Barr virus reactivation. Journal of Virology. 2026;100(7). doi:10.1128/jvi.00613-26

BibTeX
@article{Sugiokto2026,
  author = {Sugiokto, Febri Gunawan and Liu, Yuxin and Li, Renfeng},
  title = {Proteomic screening identifies HNRNPA2B1 as an epigenetic repressor of Epstein-Barr virus reactivation},
  journal = {Journal of Virology},
  year = {2026},
  volume = {100},
  number = {7},
  doi = {10.1128/jvi.00613-26}
}
Kostenlos starten →